Psychopharmacology during pregnancy: infant considerations
Walter E, Epperson C. Psychopharmacology during pregnancy: infant considerations. 2002, 642-653. DOI: 10.1093/oso/9780195141733.003.0048.Peer-Reviewed Original ResearchMajor birth defectsHealth care providersNeonatal toxicityDrug exposureMedical recordsBehavioral teratogenicityMental illnessWomen's health care providersBirth defectsPatients' medical recordsNeurobehavioral disturbancesPregnant womenFetal teratogenicityBaseline riskPsychoactive medicationsCare providersGeneral populationMedicationsPregnancyAdverse effectsTeratogenicityFetusesIllnessIncidenceRisk